{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:31Z","timestamp":1789146811402,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272908"],"award-info":[{"award-number":["82272908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109579","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:32:34Z","timestamp":1786548754000},"page":"109579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4367-4011","authenticated-orcid":false,"given":"Zhulin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojie","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangju","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3499-8465","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.lungcan.2026.109579_b0005","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0010","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0015","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41598-017-01571-0","article-title":"Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0020","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0169-5002(02)00072-7","article-title":"Staging small cell lung cancer: veterans administration lung study group versus International Association for the study of lung cancer-what limits limited disease?","volume":"37","author":"Micke","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109579_b0025","doi-asserted-by":"crossref","DOI":"10.1177\/10732748251334434","article-title":"Immunotherapy for limited-stage small cell lung cancer: innovative treatments and future perspectives","volume":"32","author":"Jin","year":"2025","journal-title":"Cancer Control"},{"issue":"14","key":"10.1016\/j.lungcan.2026.109579_b0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"ADRIATIC investigators. Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109579_b0035","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.medj.2024.10.004","article-title":"ADRIATIC: when face value is enough","volume":"5","author":"Addeo","year":"2024","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/cancers13030390","article-title":"Surgery in small-cell lung cancer","volume":"13","author":"Martucci","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/s12957-023-03196-2","article-title":"Surgery for stage IIB-IIIB small cell lung cancer","volume":"21","author":"Huang","year":"2023","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109579_b0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/SLA.0000000000002287","article-title":"Long-term survival after surgery compared with concurrent chemoradiation for node-negative small cell lung cancer","volume":"268","author":"Yang","year":"2018","journal-title":"Ann. Surg."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109579_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210001","article-title":"The role of surgery in stage I to III small cell lung cancer: a systematic review and meta-analysis","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41421-025-00838-5","article-title":"Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I\u2012III small-cell lung cancer: a phase 2 trial (LungMate-005)","volume":"11","author":"Sun","year":"2025","journal-title":"Cell Discov."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109579_b0065","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1097\/JS9.0000000000000501","article-title":"A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (cohort study)","volume":"109","author":"Duan","year":"2023","journal-title":"Int. J. Surg."},{"issue":"15","key":"10.1016\/j.lungcan.2026.109579_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70125","article-title":"A comprehensive study on clinical outcomes and safety of neoadjuvant immunotherapy combined with chemotherapy in limited-stage small cell lung cancer","volume":"16","author":"Ge","year":"2025","journal-title":"Thorac Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109579_b0075","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijc.70153","article-title":"Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited-stage small-cell lung cancer: a retrospective, multi-center, real-world study","volume":"158","author":"Zhao","year":"2026","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109579_b0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109579_b0085","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1470-2045(21)00405-8","article-title":"Pathological complete response as a surrogate endpoint after neoadjuvant therapy for lung cancer","volume":"22","author":"Huynh","year":"2021","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12967-023-04526-4","article-title":"Neoadjuvant chemotherapy remodels the tumor immune microenvironment by increasing activated and cytotoxic T cell, decreasing B cells and macrophages in small cell lung cancer","volume":"21","author":"Shang","year":"2023","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109579_b0100","doi-asserted-by":"crossref","first-page":"748","DOI":"10.21037\/tlcr.2019.10.09","article-title":"Characterization of PD-L1 protein expression and CD8+ tumor-infiltrating lymphocyte density, and their associations with clinical outcome in small-cell lung cancer","volume":"8","author":"Sun","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109579_b0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathological assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109579_b0115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1378\/chest.111.4.1089","article-title":"A pilot phase 2 study of surgical treatment after induction chemotherapy for resectable stage I to IIIA small cell lung cancer","volume":"111","author":"Fujimori","year":"1997","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109579_b0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/icvts\/ivu262","article-title":"Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?","volume":"19","author":"Xu","year":"2014","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109579_b0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41591-020-01188-3","article-title":"Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)","volume":"27","author":"Menzies","year":"2021","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109579_b0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal junction adenocarcinoma (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109579_b0135","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/JTO.0000000000000226","article-title":"Japanese Joint Committee of Lung Cancer Registry. Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004","volume":"9","author":"Takei","year":"2014","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2005.04.1202","article-title":"Neuroendocrine neoplasms of the lung: a prognostic spectrum","volume":"24","author":"Asamura","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109579_b0145","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","article-title":"Developmental relationships of four exhausted CD8+ T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms","volume":"52","author":"Beltra","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccell.2025.01.012","article-title":"Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer","volume":"43","author":"Chen","year":"2025","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109579_b0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109579_b0160","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1078-0432.CCR-23-1316","article-title":"Platinum-based chemotherapy attenuates the effector response of CD8 T cells to concomitant PD-1 blockade","volume":"30","author":"Mariniello","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109579_b0165","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/s41598-024-52687-z","article-title":"Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2026.109579_b0170","doi-asserted-by":"crossref","DOI":"10.1186\/s13019-026-04366-5","article-title":"A study of postoperative pathologic complete response (pCR) following neoadjuvant chemoimmunotherapy in limited-stage small cell lung cancer (LS-SCLC)","author":"Chunmao","year":"2026","journal-title":"J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109579_b0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.21037\/tlcr-2025-1-1496","article-title":"Neoadjuvant or conversion anti-PD-1\/PD-L1 immunotherapy combined with chemotherapy improves 2-year survival and achieves high pathological complete response rate in patients with stage IIB-IIIB small-cell lung cancer","volume":"15","author":"Gao","year":"2026","journal-title":"Transl. Lung Cancer Res."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109579_b0180","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.21037\/tlcr-2025-438","article-title":"Efficacy and safety of neoadjuvant chemotherapy with or without PD-L1\/PD-1 inhibitors in surgically limited-stage small-cell lung cancer","volume":"14","author":"Shi","year":"2025","journal-title":"Transl. Lung Cancer Res."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109579_b0185","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.21037\/tlcr-2025-490","article-title":"Surgical treatment of small-cell lung cancer: long-term prognosis and patterns of adjuvant therapy","volume":"14","author":"Cui","year":"2025","journal-title":"Transl. Lung Cancer Res."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:55:31Z","timestamp":1789145731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":37,"alternative-id":["S0169500226006409"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109579","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109579"}}